Tag: Biopharmaceutical
Fair Prospects ahead for Sirona Biochem with Grant of Key Patent...
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067, its...
The Emerging Paradigm in HIV Therapeutics Offers Hope for a Cure
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of infections...
Emerging Treatment Paradigms in Focal Segmental Glomerulosclerosis (FSGS)
Focal segmental glomerulosclerosis (FSGS) is a disease caused by the degeneration of glomeruli, the filtering system of the kidney’s and is caused by factors...
Cortexyme: Addressing Unmet Needs in the Alzheimer’s Market
The stocks of Cortexyme, Inc (NASDAQ: CRTX), a clinical stage biopharmaceutical company engaged in developing novel therapeutics for Alzheimer’ disease, surged by almost 70%...
Zolmitriptan Derivatives and Novel Drug Delivery Systems Aim to treat Acute...
Migraine is a genetic predisposition to moderate-to-severe headaches caused due to stress, physiological factors such as lack of sleep, hunger and environmental triggers such...
Recent Advances in Gene Therapy and Small Molecule Inhibitors show promise...
Sjogren’s, named after its discoverer Henrik Sjögren, is the most prevalent systemic autoimmune disease that predominantly affects women. This disorder is manifested in the...
Emerging treatment approaches in Pruritus
Pruritus is characterized by an uncomfortable and persistent urge to scratch caused either due to a skin disorder or an underlying systemic disease such...
CHALLENGING INSOMNIA BY INNOVATIVE RE-ENGINEERING OF THE NEURAL PATHWAYS
The Global Market for Insomnia is estimated to reach $5,488 million by 2023 from $4,093 million in 2016 at a CAGR of 4.2% according to a report...
We are looking for talented interns to learn and help investors find valuable companies.